VANCOUVER, BC, June 1, 2021 /PRNewswire/ – Pontus Protein Ltd. (TSXV: HULK) (OTCQB: HLKKF) (FSE: 8YC) (“Pontus” or the “Company“), is pleased to announce that its common shares have commenced trading on the OTCQB Venture Marketplace (“OTCQB“) in the United States under the symbol “HLKKF”.
The OTCQB is a US trading platform that is operated by the OTC Markets Group in New York providing access to the significant US investor base. Pontus’ OTCQB information can be found on the OTC Markets website: https://www.otcmarkets.com/stock/HLKKF/overview.
Connor Yuen, CEO of Pontus, stated: “Our listing in the US on the OTCQB allows us to offer our current and future US investors easier access to buy and trade Pontus shares in the very active plant protein market. It will also increase visibility and access to the highly active agritech market in the US. This is an excellent opportunity to expand our investor base beyond Canada and Europe.”
Pontus’ common shares are now available through the major brokers in the US, including TD Ameritrade, Fidelity, Tradestation, Interactive Brokers, E-Trade, Ally Invest and Charles Schwab.
With the commencement of trading on the OTCQB, Pontus will now be available for trading on three marketplaces around the world including the Frankfurt Stock Exchange, the world’s third largest exchange, and the Toronto Stock Venture Exchange.
OTCQB trading is non-dilutive to existing Pontus shareholders, as no new common shares are being issued to enable trading on the OTCQB.
About Pontus Protein Ltd.
Pontus Protein Ltd. is a Vancouver, B.C. based company that grows water lentil protein for commercial use. Pontus is reinventing agriculture with their proprietary Closed Environment Vertical Aquaponic System (CEVAS) – the farming of the future. Pontus specializes in the indoor vertical farming of water lentils that use 95% less water than traditional agriculture and no pesticides or chemicals. Pontus is committed to solving the global food crisis by providing access to sustainable indoor biosecure pure plant based proteins. Pontus’ water lentils can be harvested every 24 hours, exceed organic certification, and can be grown in any climate in a relatively small area. Our water lentil protein is filled with antioxidants, minerals, vitamins and all the amino acids, making a complete protein food source. Pontus aims to revolutionize the plant based sector as the entire sector is currently based on two main protein sources: soy and pea. Water lentil protein is far superior to pea and soy protein. It contains over 40% protein vs. 5-36% protein*, and Pontus aims to be the base protein for plant based food products, leading to the movement transitioning the world from meat based to plant based proteins.
To learn more, please visit pontuswaterlentils.com.
On behalf of the Board of Directors
Connor Yuen, CEO
Pontus Protein Ltd.
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, Pontus’ ability to revolutionize the plant based sector. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. These risks include, but are not limited to, the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic, the failure of Pontus to receive the necessary approvals from the Canadian Food Inspection Agency for its products and facilities, the inability to complete Pontus’ Surrey-based production facility, as well as other general business, economic, or market related risks beyond the director control of the Company and which may affect the Company’s business, operations, or products. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Pontus Protein Ltd.